Kansas Agricultural Experiment Station Research Reports
Volume 0
Issue 1 Cattleman's Day (1993-2014)

Article 1436

2010

Capacity of the bovine intestinal mucus and its components to
support Escherichia coli O157:H7 growth
C. Aperce
J. Heidenreich
James S. Drouillard

Follow this and additional works at: https://newprairiepress.org/kaesrr
Part of the Other Animal Sciences Commons

Recommended Citation
Aperce, C.; Heidenreich, J.; and Drouillard, James S. (2010) "Capacity of the bovine intestinal mucus and
its components to support Escherichia coli O157:H7 growth," Kansas Agricultural Experiment Station
Research Reports: Vol. 0: Iss. 1. https://doi.org/10.4148/2378-5977.2839
This report is brought to you for free and open access by New
Prairie Press. It has been accepted for inclusion in Kansas
Agricultural Experiment Station Research Reports by an
authorized administrator of New Prairie Press. Copyright 2010
Kansas State University Agricultural Experiment Station and
Cooperative Extension Service. Contents of this publication
may be freely reproduced for educational purposes. All other
rights reserved. Brand names appearing in this publication are
for product identification purposes only. No endorsement is
intended, nor is criticism implied of similar products not
mentioned. K-State Research and Extension is an equal
opportunity provider and employer.

Capacity of the bovine intestinal mucus and its components to support
Escherichia coli O157:H7 growth
Abstract
Escherichia coli O157:H7 contamination of human food products is a major concern for the beef industry.
The pathogens responsible for outbreaks often originate from cattle, and E. coli O157:H7 can thrive in
healthy cattle. To control contamination in the food chain, it is essential to understand how this pathogen
is able to grow and compete with other bacteria in the gastrointestinal tracts of cattle. Previous studies
have shown that bovine intestinal mucus supports bacterial colonization and can selectively influence
makeup of the bacterial population. Intestinal mucus is made of mucins, which are gel-forming
glycoproteins. Mucin molecules contain sialic acid that must be removed by neuraminidase enzyme to
allow for complete degradation of mucin. E. coli O157:H7 lacks neuraminidase and should have little
ability to degrade the complex mucin molecules. Our objective was to evaluate bovine intestinal mucus
and its components in terms of their capacity to support E. coli O157:H7 growth in the presence or
absence of feces and to understand the roles various enzymes play in this process.
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Capacity of the Bovine Intestinal Mucus and
Its Components to Support Escherichia coli
O157:H7 Growth1
C. Aperce, J. Heidenreich, and J. Drouillard

Introduction

Escherichia coli O157:H7 contamination of human food products is a major concern
for the beef industry. The pathogens responsible for outbreaks often originate from
cattle, and E. coli O157:H7 can thrive in healthy cattle. To control contamination
in the food chain, it is essential to understand how this pathogen is able to grow and
compete with other bacteria in the gastrointestinal tracts of cattle.
Previous studies have shown that bovine intestinal mucus supports bacterial colonization and can selectively influence makeup of the bacterial population. Intestinal mucus
is made of mucins, which are gel-forming glycoproteins. Mucin molecules contain sialic
acid that must be removed by neuraminidase enzyme to allow for complete degradation
of mucin. E. coli O157:H7 lacks neuraminidase and should have little ability to degrade
the complex mucin molecules. Our objective was to evaluate bovine intestinal mucus
and its components in terms of their capacity to support E. coli O157:H7 growth in
the presence or absence of feces and to understand the roles various enzymes play in
this process.

Experimental Procedures

Intestinal tissues from freshly harvested cattle were collected and transported to our
laboratory in chilled saline. Sections of the ileum and colon were washed with buffer
solution, and mucus was harvested by gently scraping the epithelium. We prepared a
mix of five selected strains of Shiga toxin-producing E. coli O157:H7 resistant to nalidixic acid (NalR) and added the mix to a buffer or a similar amount of fecal inoculums
collected from the rectum of a steer fed a high-grain diet.
Subsequently, we added harvested intestinal mucus or individual mucus components
to the culture to assess which components were most capable of supporting NalR E. coli
O157:H7 growth. Intestinal mucus was added at a concentration of 10 mg/mL. Single
components of mucus (galactose, D-galacturonic acid, D-gluconic acid, D-glucuronic
acid, mannose, L-alpha-phosphatidylserine, sialic acid, and N-acetyl-D-glucosamine)
were added at the same concentration, except for L-alpha-phosphatidylserine, which
was added at 1 mg/mL. Initial concentrations of E. coli O157:H7 and fecal bacteria in
the cultures were 103 and 104 CFU/mL, respectively.
We also evaluated the impact of adding enzymes and enzyme inhibitors associated with
mucus degradation on E. coli O157:H7 growth. Proteases, endoglycosidases, sialidases,
or lipases were added to the batches at a concentration of one unit per milliliter. Betagalactosidase inhibitor was added at a final concentration of 200 µM, and protease
inhibitor was added at either 0.25 or 2.5 mL/g of E. coli O157.
1
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After 0, 6, 8, and 12 hours of anaerobic incubation at 104°F on a laboratory shaker,
we plated 100 µL of culture at different dilutions on agar selective for NalR E. coli
O157:H7. After incubating the plates for 24 hours at 98°F, we counted the NalR E coli
O157:H7 colonies and established the NalR E coli O157:H7 growth within the different batches (expressed in Log10 of CFU/mL).

Results and Discussion

There were no significant differences (P>0.10) in E. coli O157:H7 growth between
mucus derived from the large intestine (colon) and small intestine (ileum). The bacteria
increased from 103 CFU/mL of culture at time zero to 107 to 108 CFU/mL at hour 8.
There was an overall time effect on bacteria growth but no significant difference
between hour 8 and 12, which drove us to use hour 8 as a point of comparison. Presence
or absence of fecal inoculums in the culture affected (P<0.01) E. coli O157:H7 growth.
The final concentration of bacteria decreased from 107 to 105 CFU/mL, which is likely
due to competition for nutrients with the fecal bacteria.
Figure 1 depicts E. coli O157:H7 growth after 8 hours of anaerobic incubation without
feces but with whole mucus or selected components of mucous as substrates. With the
exception of L-alpha-phosphatidylserine, almost all of the mucus components tested
increased growth of the bacteria compared with the batch containing only buffer
(P<0.05). However, mucus originating from the large and small intestines supported
greater growth than the individual mucus fractions (P<0.05). Of the individual mucus
components evaluated, only gluconic acid resulted in growth similar to that achieved
with whole intestinal mucus. These observations suggest E. coli O157:H7 may need a
combination of components to ensure optimal growth or that the bacteria are utilizing
a key element present in the mucus that we did not evaluate in this experiment.
In our attempt to analyze the stimulatory effect of mucus-degrading enzymes on
growth of Shiga toxin-producing E. coli O157:H7, we found no significant difference in growth of cultures treated with enzymes or protease inhibitors compared with
untreated batches (P>0.05). Conversely, as illustrated in Figure 2, addition of betagalactosidase enzyme inhibitor increased the growth of NalR E. coli O157:H7 cultured
with either small or large intestinal mucus (P<0.05). The increase of growth, instead
of the expected inhibition, could be due to the bacteria’s inability to use the inhibitor
as a source of protein. However, the amount of inhibitor added to the culture was very
small and, therefore, seems an unlikely explanation. It is equally possible that mucus
galactosides that have not been enzymatically degraded are more stimulatory to E. coli
O157:H7 growth. Additional controlled experiments are needed to further investigate
the increase of growth induced by the beta-galactosidase inhibitors.
Figure 3 illustrates E. coli O157:H7 growth in response to small intestinal mucus or
sialic acid substrates in the presence or absence of a fecal inoculum. E. coli O157 growth
was significantly lower in sialic acid than in mucus (P<0.01), indicating the pathogen
has limited capacity to use sialic acid as a substrate for growth. When fecal inoculum
was added to the culture with small intestinal mucus, there was a significant decrease
in E. coli growth compared with the same culture without feces. This again suggests the
bacteria are competing for nutrients. However, E. coli O157:H7 growth increased when
fecal inoculum was added to the culture containing sialic acid. Bacteria present in feces
30
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may have the ability to degrade sialic acid, thus allowing E. coli O157:H7 to use the
intermediates or end products of the degradation as a substrate for growth.
Cattle fed distillers grains have been shown to have an increase in E. coli O157 shedding, and distillers grains contain a substantial proportion of yeast, which has a high
sialic acid content (3% of dry weight). It is possible that sialic acid or other glycoprotein
constituents of distillers grains are the active components that stimulate proliferation of
E. coli O157:H7 in cattle fed distillers grains.

Implications

This study offers insight regarding the potential of intestinal mucus and its components
to promote E. coli O157:H7 growth in cattle. Further investigations are needed to
establish whether one of these components could inhibit, or at least regulate, the proliferation of important foodborne pathogens.
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Figure 1. Growth of nalidixic acid-resistant Escherichia coli O157:H7 on small intestinal
mucus, large intestinal mucus, or components of mucus after 8 hours of incubation.
Cultures were inoculated with 103 CFU/mL of nalidixic acid-resistant E. coli O157:H7 prior
to incubation.
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Figure 2. Growth of nalidixic acid-resistant Escherichia coli O157:H7 with small or large
intestinal mucus in the presence and absence of beta-galactosidase enzyme inhibitor.
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Figure 3. Growth of nalidixic acid-resistant Escherichia coli O157:H7 in response to small
intestinal mucus or sialic acid as substrate in the presence and absence of a fecal inoculum.
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